SCHEMBL2741563

SCHEMBL2741563

Cc1ccc(-c2ccc(-c3cc(F)c(C(F)(F)Oc4cc(F)c(F)c(F)c4)c(F)c3)c(F)c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
PDK2 Q15119 1/20 0.34
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
AKR1C3 P42330 1/20 0.33
AKR1C2 P52895 1/20 0.33
CYP1A2 P05177 1/20 0.32
MAPT P10636 1/20 0.32
CYP2C19 P33261 1/20 0.32
PTGS2 P35354 1/20 0.32
RPS6KA3 P51812 1/20 0.32
AR P10275 1/20 0.31
ERN1 O75460 1/20 0.31
PTGES2 Q9H7Z7 1/20 0.31
CYP11B1 P15538 2/20 0.31
CYP11B2 P19099 2/20 0.31
GPR3 P46089 1/20 0.31
GRM2 Q14416 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15933152 1.00 ALOX5AP (0.34) ALOX5APFEN1PDK2PDE3BPDE3A
SCHEMBL12625439 0.99 ALOX5AP (0.36) ALOX5APFEN1PDK2PDE3BPDE3A
SCHEMBL12624690 0.96 ALOX5AP (0.39) ALOX5APFEN1PDK2PDE3BPDE3A
SCHEMBL17951017 0.96 PDE3B (0.34) ALOX5APFEN1PDK2PDE3BPDE3A
SCHEMBL12814531 0.95 ALOX5AP (0.38) ALOX5APFEN1PDK2PDE3BPDE3A
SCHEMBL14767335 0.94 ALOX5AP (0.39) ALOX5APFEN1PDK2PDE3BPDE3A
SCHEMBL15374870 0.94 ALOX5AP (0.39) ALOX5APFEN1PDK2PDE3BPDE3A
SCHEMBL17951018 0.92 ALOX5AP (0.40) ALOX5APFEN1PDK2PDE3BPDE3A
SCHEMBL10259805 0.92 ALOX5AP (0.34) ALOX5APFEN1PDK2PDE3BPDE3A
SCHEMBL13447418 0.92 ALOX5AP (0.34) ALOX5APFEN1PDK2PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 419 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043782-B2 Liquid crystalline medium MERCK PATENT GMBH (DE) 2024-07-23 US disclosed
US-12043781-B2 Liquid-crystalline medium MERCK PATENT GMBH (DE) 2024-07-23 US disclosed
US-20240072425-A1 AROMATIC ISOTHIOCYANATES MERCK PATENT GMBH (DE) 2024-02-29 US disclosed
US-20240072425-A1 AROMATIC ISOTHIOCYANATES MERCK PATENT GMBH (DE) 2024-02-29 US disclosed
US-11834599-B2 Aromatic isothiocyanates MERCK PATENT GMBH (DE) 2023-12-05 US disclosed
US-20230383186-A1 LIQUID-CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2023-11-30 US disclosed
US-20230383186-A1 LIQUID-CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2023-11-30 US disclosed
US-11788009-B2 Liquid-crystalline medium for use in a switching element MERCK PATENT GMBH (DE) 2023-10-17 US disclosed
US-20230323209-A1 LIQUID-CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2023-10-12 US disclosed
US-20230313043-A1 OPTICAL COMPONENT MERCK PATENT GMBH (DE) 2023-10-05 US disclosed
US-20100301270-A1 LIQUID-CRYSTALLINE MEDUIM MERCK PATENT GMBH (DE) 2010-12-02 US disclosed
US-20100224827-A1 LIQUID-CRYSTALLINE MEDIUM WITTEK MICHAEL 2010-09-09 US disclosed
US-20100219375-A1 LIQUID-CRYSTALLINE MEDIUM WITTEK MICHAEL 2010-09-02 US disclosed
US-7763329-B2 Liquid-crystalline medium MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-07-27 US disclosed
US-20100181533-A1 Liquid-crystal compounds and LC media MERCK KGAA (DE) 2010-07-22 US disclosed
WO-2010022891-A1 LIQUID CRYSTALLINE MEDIUM AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2010-03-04 WO disclosed
US-20090289223-A1 LIQUID-CRYSTALLINE MEDIUM WITTEK MICHAEL 2009-11-26 US disclosed
US-7595101-B2 Liquid-crystalline medium MERCK PATENT GMBH (DE) 2009-09-29 US disclosed
WO-2009033564-A2 ELECTRO-OPTICAL LIGHT CONTROL ELEMENT, ELECTRO-OPTICAL DISPLAY AND CONTROL MEDIUM MERCK PATENT GMBH (DE) 2009-03-19 WO disclosed
US-20080083904-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240072425-A1 AROMATIC ISOTHIOCYANATES TRPA1, TRPC1, CRY1 ALOX5AP 4739/4885FEN1 4188/4885PDK2 4357/4885
US-20080083904-A1 LIQUID-CRYSTALLINE MEDIUM NEFM, OSBP, ALPG ALOX5AP 4608/4885FEN1 3821/4885PDK2 2955/4885
US-20100181533-A1 Liquid-crystal compounds and LC media VCL, LCT, NEFM ALOX5AP 361/4885FEN1 4446/4885PDK2 2122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.